Phio Pharmaceuticals Corporation.

PHIO

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report10/13/26 8-KChange in Directors or Officers; Shareholder Vote Results09/28/26 8-KOther Events09/14/26 8-KResults of Operations08/06/26 8-KChange in Directors or Officers; Other Events07/21/26

Prospectuses and Registrations

S-8Registration of securities for employees09/28/26 424B5Prospectus supplement04/08/26 424B3Prospectus12/04/25 S-3Shelf registration11/20/25 S-8Registration of securities for employees09/11/25

Proxies

DEF 14ADefinitive proxy08/14/26 DEFA14AAdditional proxy materials08/14/26 DEFA14AAdditional proxy materials08/28/25 DEF 14ADefinitive proxy07/30/25 DEFA14AAdditional proxy materials07/30/25

Ownership

Form 4Insider transaction09/30/26 Form 4Insider transaction09/29/26 Form 4Insider transaction09/29/26 Form 4Insider transaction09/29/26 Form 4Insider transaction09/25/26

Other

ARSAnnual report to shareholders08/14/26 EFFECTRequest for effectiveness12/03/25 CORRESPCorrespondence with the SEC12/01/25 DD11/12/25 EFFECTRequest for effectiveness08/22/25